With firearms playing such a major role in world history, it is not surprising that many older guns have become ...

BALTIMORE — Colt Emerson has made progress in his recovery from what he described as a “super minor” back ailment, but the Mariners bullpen took another hit when Matt Brash landed on the injured list ...

BALTIMORE — Colt Emerson has made progress in his recovery from what he described as a "super minor" back ailment, but the Mariners bullpen took taken another hit when Matt Brash landed on the injured ...

BALTIMORE — The Mariners, suddenly, are digging deep into their infield depth chart. An hour before Monday’s first pitch against the Orioles, Colt Emerson was scratched from the Mariners lineup ...

The atmosphere in the pavilion turned electric as the highly anticipated Flightline colt (Hip 1056) made his entrance into the ring during the April 17 finale of the Ocala Breeders' Sales Spring ...

Meara covers streaming service news for CNET. She graduated from the University of Texas at Austin with a degree in journalism. When she's not writing, she likes to dote over her cat, sip black coffee ...

PHOENIX — Another day, another record-setting contract extension for a prospect who has yet to even set foot in the major leagues. The Seattle Mariners have reached an agreement on a guaranteed ...

Colt Emerson's extension is $13 million more than the previous record set by Jackson Chourio. Rick Scuteri / Imagn Images Less than two weeks after missing out on a spot on the Seattle Mariners’ ...

Weight loss drugmaker Novo Nordisk will cut the list prices of Ozempic and Wegovy by up to 50% beginning in 2027, the company announced on Tuesday. Wegovy currently carries a list price of $1,349 per ...

Novo Nordisk NOVO.B0.73%increase; up pointing triangle plans to slash U.S. list prices for its popular weight-loss and diabetes drugs Wegovy and Ozempic by up to half starting next year. Under the ...

Novo Nordisk on Tuesday announced plans to cut the list price of its popular diabetes and weight-loss drugs Ozempic and Wegovy by as much as 50% in the U.S. next year. The Danish drugmaker indicated ...

Amid efforts on several fronts to improve the affordability of its GLP-1 medications for diabetes and obesity, Novo Nordisk is taking a new approach by aiming straight for semaglutide’s list price.